SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joseph Strohsahl who wrote (1377)6/7/1999 9:41:00 AM
From: John S. Baker  Read Replies (1) of 1510
 
I have not given up on IMNR, and keep reminding myself that it is a multiple-product (therapy) company with several other useful products in the testing pipeline.

But I find it a weird quirk of fate that the testing of Remune, a therapy which is supposed to keep people from dying of AIDS, is halted because not enough people are dying of AIDS. Something circular in that discussion, but I can't point it out right away.

But of course it's good news for the AIDS patients who are still alive.

JSb.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News